this page only  
Join BIO   |   Member Directory   |    Contact BIO    
Biotechnology Industry Organization

Home
About BIO
Conferences & Events
Past BIO Events
Industry Calendar
State/Int'l Calendar
Members.BIO.org
BIO News Online
BIO Bulletins
Suggestion Box
Membership Directory
BIO Videos
News & Media
BIO Blogs & Podcasts
National Issues
Health
Food & Agriculture
Industrial & Environmental
Bioethics
Intellectual Property
Regulatory
Tax & Financial
State & Local Issues
State by State Initiatives
Letters, Testimony & Comments
Speeches & Publications
Industry At-a-Glance
Business & Finance
BIO News


Saturday, November 07, 2009

Solutions for Health — Healthcare

Click here for a printer-friendly page Printer Friendly
solutions Overview
Healthcare
Agriculture
Industrial & Environmental
Economic Growth
Resources

Ask your constituents: Virtually every American has either benefited from a biotech healthcare product or knows someone who has. Biotechnology has created more than 200 medicines and vaccines, along with hundreds of diagnostics that make it possible to detect disease earlier, more easily and more precisely.

Now, biotechnology researchers are developing a new generation of medicines that will revolutionize healthcare.

The Pipeline
Here is what’s coming: Biotechnology companies are developing new drugs and vaccines for literally hundreds of diseases and conditions. Some of these products will treat diseases that afflict millions, while others target so-called orphan diseases, conditions that in some cases afflict only a few thousand Americans.

Also coming are new diagnostic tests that will help people detect disease — and predisposition to disease — earlier and more accurately than ever before. Other diagnostics will help patients choose the medicines that are most likely to benefit them.

Alzheimer’s disease
At least 55 biotech companies are studying and developing products for this disease, expected to afflict 13 million Americans by 2050.

Cancer
Biotech firms are developing two-thirds of the 400 drugs now in clinical testing for various cancers.

Biodefense
More than 100 biotech companies are developing medicines, vaccines, diagnostics and sensors against biological warfare agents.

Obesity
At least 52 biotech companies are engaged in R&D on obesity, a condition linked to many health problems, including diabetes, cardiovascular disease and even cancer.

Transplants
Biotech firms are exploring the use of stem cells and animal sources for transplantable cells, tissues and organs to treat diseases that combined afflict more than 100 million Americans.

Vaccines
Infectious diseases remain one of the leading killers worldwide, accounting for about a third of all deaths. Biotech companies are developing vaccines to attack HIV, papillomavirus, herpes, cholera, yellow fever, dengue and many other infections.

The list goes on and on. Biotechnology is developing products for literally hundreds of conditions, including:

contact us | terms of use | privacy policy
© 2009 | Biotechnology Industry Organization | 1201 Maryland Ave., SW, Ste. 900 | Washington, D.C. 20024